The company said earlier that it has not delivered any Cambodian NHPs held by it in the U.S. since November 16, 2022. If the company is not able to resume such deliveries before the end of the quarter, its sales, earnings and liquidity in the first fiscal quarter ended December 31, 2022, will be negatively impacted. The company is cooperating with the relevant regulators in this matter, and is attempting to obtain additional clarity on the application of the Supplier’s issues to the NHPs that the company holds in the U.S., as well as the impacts on the broader industry, research markets, and government agencies which use these research models in the U.S.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NOTV:
- Inotiv Stock Plunges 24% on Weak Revenue Guidance
- Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results
- Inotiv management to meet virtually with Lake Street
- Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
- Inotiv announces new site openings, capacity expansion
